These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17566387)

  • 1. [The 2006 American Heart Association selection of the "top ten advances in heart disease and stroke research"].
    Kulbertus H
    Rev Med Liege; 2007 Apr; 62(4):190-5. PubMed ID: 17566387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack.
    Chaturvedi S; Zivin J; Breazna A; Amarenco P; Callahan A; Goldstein LB; Hennerici M; Sillesen H; Rudolph A; Welch MA;
    Neurology; 2009 Feb; 72(8):688-94. PubMed ID: 18768917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Sillesen H; Amarenco P; Hennerici MG; Callahan A; Goldstein LB; Zivin J; Messig M; Welch KM;
    Stroke; 2008 Dec; 39(12):3297-302. PubMed ID: 18845807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Journal Watch: evidence that Atorvastatin reduces the risk of stroke and myocardial infarction in patients with type 2 diabetes, but with no evidence of dyslipidaemia.
    Gangaidzo IT
    Cent Afr J Med; 2005; 51(11-12):125-6. PubMed ID: 17447346
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensive Lipitor therapy reduced heart attack and stroke by one-third in patients with chronic kidney disease.
    Cardiovasc J S Afr; 2007; 18(1):62. PubMed ID: 17393007
    [No Abstract]   [Full Text] [Related]  

  • 6. Atorvastatin for acute coronary syndromes.
    Schwartz GG; Olsson AG; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A; Chaitman BR
    JAMA; 2001 Aug; 286(5):533-5. PubMed ID: 11476650
    [No Abstract]   [Full Text] [Related]  

  • 7. [After TIA and stroke: a statin for secondary prevention?].
    MMW Fortschr Med; 2006 Jun; 148(24):10. PubMed ID: 16850798
    [No Abstract]   [Full Text] [Related]  

  • 8. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Bloom JM
    N Engl J Med; 1999 Dec; 341(24):1854-5. PubMed ID: 10610466
    [No Abstract]   [Full Text] [Related]  

  • 9. Statin therapy and the elderly: SAGE advice?
    Gotto AM
    Circulation; 2007 Feb; 115(6):681-3. PubMed ID: 17296867
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Callahan A; Amarenco P; Goldstein LB; Sillesen H; Messig M; Samsa GP; Altafullah I; Ledbetter LY; MacLeod MJ; Scott R; Hennerici M; Zivin JA; Welch KM;
    Arch Neurol; 2011 Oct; 68(10):1245-51. PubMed ID: 21670382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin therapy after stroke or transient ischemic attack.
    Elkind MS
    N Engl J Med; 2006 Nov; 355(22):2369; author reply 2370-1. PubMed ID: 17139774
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack.
    Castilla-Guerra L; Fernandez-Moreno Mdel C; Jimenez-Hernandez MD; Chaturvedi S
    Neurology; 2009 Jul; 73(3):248; author reply 248-9. PubMed ID: 19620617
    [No Abstract]   [Full Text] [Related]  

  • 13. Statins: not just for the young or the faint of heart.
    Coull BM; Johnston SC
    Neurology; 2009 Feb; 72(8):684-5. PubMed ID: 19237695
    [No Abstract]   [Full Text] [Related]  

  • 14. Stroke--an equal opportunity for the initiation of statin therapy.
    Kent DM
    N Engl J Med; 2006 Aug; 355(6):613-5. PubMed ID: 16899782
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
    Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Thomason MJ; Mackness MI; Charlton-Menys V; Fuller JH;
    Lancet; 2004 Aug 21-27; 364(9435):685-96. PubMed ID: 15325833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [AVERT [The Atorvastatin versus Revascularization Treatment]].
    Mokuno H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():436-41. PubMed ID: 11347110
    [No Abstract]   [Full Text] [Related]  

  • 17. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):7-8. PubMed ID: 16455005
    [No Abstract]   [Full Text] [Related]  

  • 18. Reducing residual risk in secondary prevention of cardiovascular disease.
    Stone NJ
    Circulation; 2012 Apr; 125(16):1958-60. PubMed ID: 22461417
    [No Abstract]   [Full Text] [Related]  

  • 19. Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction.
    Teshima Y; Yufu K; Akioka H; Iwao T; Anan F; Nakagawa M; Yonemochi H; Takahashi N; Hara M; Saikawa T
    J Cardiol; 2009 Feb; 53(1):58-64. PubMed ID: 19167639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin for stroke prevention.
    Med Lett Drugs Ther; 2006 Sep; 48(1243):75-6. PubMed ID: 16977287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.